Fulphila Injection
Product Images NDC 83257-005

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Fulphila (NDC 83257-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instructions For Use Syringe Before Use (Image 01)

An instructional illustration showing the parts of a Fulphila (pegfilgrastim-jmdb) prefilled injection syringe before use. Labeled components include the plunger rod, finger grips, label and expiration date on the syringe barrel, needle safety guard, needle safety spring, and the gray needle cap.*

FDA Label Image

Instructions For Use Syringe After Use (Image 02)

An instructional diagram showing the components of a used injection device after use for Fulphila (pegfilgrastim-jmdb) 6 mg/.6 mL subcutaneous injection. Labeled parts include the used plunger rod, used syringe barrel, used needle with safety spring, and a detached gray needle cap.*

FDA Label Image

Instructions For Use Figure 01 (Image 03)

An instructional illustration showing three items commonly used in injection procedures: an adhesive bandage, a cotton ball, and an alcohol wipe, alongside a disposal container for safe discarding of medical waste.*

FDA Label Image

Instructions For Use Figure 02 (Image 04)

An instructional illustration showing a hand holding a prefilled injection device, with arrows and text indicating the location to grasp the device. The image demonstrates proper handling technique for a subcutaneous injection.*

FDA Label Image

Instructions For Use Figure 03 (Image 05)

An illustrated cross-sectional diagram of a Fulphila (pegfilgrastim-jmdb) 6 mg/.6 mL subcutaneous injection device, highlighting labeled parts: label, expiration date, medicine inside the device, and gray needle cap.*

FDA Label Image

Instructions For Use Figure 04 (Image 06)

An anatomical illustration showing recommended subcutaneous injection sites. The front view highlights the upper arms, stomach area (abdomen), and thighs, while the rear view shows the upper arms and upper outer area of the buttocks. Each injection site is shaded to indicate appropriate areas for administration.*

FDA Label Image

Instructions For Use Figure 05 (Image 07)

An instructional illustration showing a person holding a syringe and pulling a cap or protective cover upward off the top of the syringe, demonstrating a step in preparing an injection. The syringe likely contains a liquid medication for subcutaneous injection.*

FDA Label Image

Instructions For Use Figure 06 (Image 08)

An instructional illustration showing hands pinching skin on the abdomen, indicating the proper site for subcutaneous injection. Arrows highlight the areas to pinch between thumb and fingers.*

FDA Label Image

Instructions For Use Figure 07 (Image 09)

An instructional illustration showing how to hold and inject with a syringe at specific angles (45° and 90°) for subcutaneous administration. The diagram includes hand positioning and the syringe inserting into the skin with a downward arrow indicating the injection direction.*

FDA Label Image

Instructions For Use Figure 08 (Image 10)

Illustration showing a hand administering a subcutaneous injection using a prefilled syringe. The syringe is positioned above the injection site on an arm, with an arrow pointing downward indicating the direction of injection.*

FDA Label Image

Instructions For Use Figure 09 (Image 11)

An instructional illustration showing the proper technique for administering a subcutaneous injection. The image depicts one hand holding an injection device perpendicular to the skin while the other hand stabilizes the area, with an arrow indicating the upward direction for removing the needle or device after injection.*

FDA Label Image

Instructions For Use Figure 10 (Image 12)

An instructional illustration showing a hand disposing of a syringe into a sharps disposal container, with a downward arrow indicating the syringe should be placed inside the container.*

FDA Label Image

Fulphila Injection 6 mg/0.6 mL Carton Label (Image 13)

Packaging label for Fulphila (pegfilgrastim-jmdb) Injection, 6 mg/0.6 mL, a subcutaneous injection in a single-dose prefilled syringe. Label shows Biocon Biologics Inc. as the manufacturer with NDC 83257-005-41. The label includes product name, strength, dosage form, route of administration, and a barcode on a white and blue background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.